Registr TULUNG (sledování nákladné pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic) - zdroj informací pro všechny pneumology

Title in English The TULUNG register (Followup of of costly pulmonary oncological treatment of advanced non-small cell cancer) - a source of information for all pulmonologists
Authors

SKŘIČKOVÁ Jana BORTLÍČEK Zbyněk HEJDUK Karel PEŠEK M. ZATLOUKAL P. KOLEK V. SALAJKA F. KOUBKOVÁ L. TOMÍŠKOVÁ Marcela GRYGÁRKOVÁ Y. HAVEL L. HRNČIARIK M. ZEMANOVÁ M. SIXTOVÁ D. ROUBEC J. ČOUPKOVÁ H. KOŠATOVÁ K. ČERNOVSKÁ M. MAREL M. VAŠÁKOVÁ M.

Year of publication 2013
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description In Czech pulmonary oncological centres, 910 NSCLC patients were treated (fist line therapy)with bevacizumab, pemetrexed, gefitinib and erlotinib between 2005 and 2013. A sizeable increse in the use of pemetrexed, the most widely used drug (399 patients) while the use of erlotinib was plateauing over the given period.

You are running an old browser version. We recommend updating your browser to its latest version.

More info